Psoriasis and Vitiligo

MEL@308nm (Monochromatic Excimer Light @ 308nm) is Deka's innovative monochromatic excimer light source.
The state-of-the-art in phototherapy for the treatment of psoriasis and vitiligo, it uses the most effective wavelength, offering numerous advantages over equivalent treatments with excimer lasers. In fact, with the MEL@308nm laser it is possible to selectively treat lesions, even when extensive, in only a few seconds without involving the healthy skin. The total irradiation is reduced to a minimum, combining the great therapeutic benefits of this wavelength with the safety of limited exposure to ultraviolet rays. A few weeks' treatment eliminates symptoms for several months. Treatment is extremely well tolerated, painless and with hardly any impact on the patient's working and social activities.

Experimentation has demonstrated the efficacy of Deka's MEL@308nm light sources for the clinical symptoms of psoriasis on elbows, knees, back, soles of the feet, and palms of the hand, generating prolonged remission of the disease and considerably enhancing the patient's quality of life.

Trials on vitiligo have demonstrated cases with an acceptable to excellent degree of re-pigmentation on the face, neck, back, abdomen, and limbs.

What is Psoriasis?

Psoriasis is chronic, relapsing, non-contagious dermatosis with an unpredictable evolution, usually characterised by roundish erythematous-desquamative patches on the elbows, knees, scalp, palms of the hand, soles of the feet, and at times involving the whole body.

It is not contagious, occurs frequently (in 2-3% of the population) and affects both sexes of all ages.

What is vitiligo?

This is an acquired pigmentation disorder in the form of depigmentated areas lacking in skin melanin. Vitiligo patches often have irregular, well-defined borders without any atrophy or hyperkeratosis.

Vitiligo affects 1-2% of the population worldwide of all ages, races, and sex.